PTPN2 and malignant colon neoplasm: The knockdown of PTPN2 in the immune system of mice resulted in the complete elimination of colon cancer foci in mice bearing colon cancer and, in combination with PD-1 inhibitors, resulted in the elimination of approximately 1/4 of tumor foci in mice bearing highly aggressive and treatment-resistant melanoma.